CAR-T Cells for HIV Infection

NCT04648046 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Cyclophosphamide
BIOLOGICAL: LVgp120duoCAR-T cells, low dose
BIOLOGICAL: LVgp120duoCAR-T cells, high dose
OTHER: Analytic Treatment Interruption

Sponsor

Steven Deeks

Collaborators

[object Object]